Voyageur Pharmaceuticals Ltd. Announces Health Canada Approval and Issuance of Product License for SmoothX; Radiographic Barium Contrast Suspension
Voyageur Pharmaceuticals Ltd. (TSXV: VM) – Initiating Coverage: Junior Resource Company Building a Fully Integrated Pharmaceutical Company - $0.39 Fair Market Value Target
Change of Name to Voyageur Pharmaceuticals Ltd., Frontier and Stock House Retained for Marketing & IR, Shares for Debt Transaction, Extension of Warrants, Resignation of Director
Voyageur Minerals’ Joint Venture Company, ImagingX Pharmaceuticals, Submits Third Barium Contrast Product to Health Canada for Registration
Voyageur Minerals Ltd Joint Venture Company, ImagingX Pharmaceuticals, Submits Second Barium Contrast Product to Health Canada for Registration
